A synergic effect between CYP2C19*2, CYP2C19*3 loss-of-function and CYP2C19*17 gain-of-function alleles is associated with Clopidogrel resistance among Moroccan Acute Coronary Syndromes patients.
about
A synergic effect between CYP2C19*2, CYP2C19*3 loss-of-function and CYP2C19*17 gain-of-function alleles is associated with Clopidogrel resistance among Moroccan Acute Coronary Syndromes patients.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
A synergic effect between CYP2 ...... e Coronary Syndromes patients.
@en
A synergic effect between CYP2 ...... e Coronary Syndromes patients.
@nl
type
label
A synergic effect between CYP2 ...... e Coronary Syndromes patients.
@en
A synergic effect between CYP2 ...... e Coronary Syndromes patients.
@nl
prefLabel
A synergic effect between CYP2 ...... e Coronary Syndromes patients.
@en
A synergic effect between CYP2 ...... e Coronary Syndromes patients.
@nl
P2093
P2860
P1433
P1476
A synergic effect between CYP2 ...... e Coronary Syndromes patients.
@en
P2093
Hafid Akoudad
Hind Hassani Idrissi
Nada El Khorb
Rachida Habbal
Wiam Hmimech
P2860
P2888
P356
10.1186/S13104-018-3132-0
P577
2018-01-18T00:00:00Z
P6179
1100474420